ConductScience.org, home

Paper40705771

Untargeted Diversity-Oriented Synthesis for the Discovery of New Antitumor Agents: An Integrated Approach of Inverse Virtual Screening, Bioinformatics, and Omics for Target Deconvolution.

Ciaglia T and 22 others. J Med Chem, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Untargeted Diversity-Oriented Synthesis for the Discovery of New Antitumor Agents: An Integrated Approach of Inverse Virtual Screening, Bioinformatics, and Omics for Target Deconvolution. Papers, record 40705771. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40705771

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Untargeted Diversity-Oriented Synthesis for the Discovery of New Antitumor Agents: An Integrated Approach of Inverse Virtual Screening, Bioinformatics, and Omics for Target Deconvolution.
PubMed
Journal
J Med Chem
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-09-16
PubMed

Authors23

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ciaglia TTania
2Napolitano VValeria
3Miranda MRMaria Rosaria
4La Gioia DDanila
5Musella SSimona
6Schiano Moriello AAniello
7Merciai FFabrizio
8Di Sarno VVeronica
9De Vita SSimonahttps://orcid.org/0000-0002-8203-3580
10Colarusso EEster
11Smaldone GGerardina
12Di Matteo FFrancesca
13Sommella EMEduardo Mariahttps://orcid.org/0000-0001-8654-6431
14Kumar PPoulami
15Allarà MMarco
16Ligresti AAlessiahttps://orcid.org/0000-0003-1787-3900
17Gomez-Monterrey IMIsabel Mhttps://orcid.org/0000-0001-6688-2606
18Bifulco GGiuseppehttps://orcid.org/0000-0002-1788-5170
19Lauro GGianluigihttps://orcid.org/0000-0001-5065-9717
20Campiglia PPietrohttps://orcid.org/0000-0002-1069-2181

Source PubMed

See all 23 authorsDownload CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Computational BiologyMajor topic
Drug DiscoveryMajor topic
Humans
Drug Screening Assays, Antitumor
Cell Line, Tumor
Apoptosis

Source PubMed

Download CSV of topics

References106

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115027865Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.J Med Chem2004https://conductscience.org/library/papers/15027865PubMed
228042841Facile Synthesis for Benzo-1,4-Oxazepine Derivatives by Tandem Transformation of C-N Coupling/C-H Carbonylation.Molecules2016https://conductscience.org/library/papers/28042841PubMed
322537682Inverse Virtual Screening allows the discovery of the biological activity of natural compounds.Bioorg Med Chem2012https://conductscience.org/library/papers/22537682PubMed
432777735Isocitrate dehydrogenase variants in cancer - Cellular consequences and therapeutic opportunities.Curr Opin Chem Biol2020https://conductscience.org/library/papers/32777735PubMed
521542600Inverse virtual screening of antitumor targets: pilot study on a small database of natural bioactive compounds.J Nat Prod2011https://conductscience.org/library/papers/21542600PubMed
632106040Recent advances in synthesis and medicinal chemistry of benzodiazepines.Bioorg Chem2020https://conductscience.org/library/papers/32106040PubMed
732796829BRD4 prevents the accumulation of R-loops and protects against transcription-replication collision events and DNA damage.Nat Commun2020https://conductscience.org/library/papers/32796829PubMed
832004460Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex.Cell2020https://conductscience.org/library/papers/32004460PubMed
928525743Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function.Mol Cell2017https://conductscience.org/library/papers/28525743PubMed
1026512697Roles of TRPM8 Ion Channels in Cancer: Proliferation, Survival, and Invasion.Cancers (Basel)2015https://conductscience.org/library/papers/26512697PubMed
1138372253Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo.ACS Chem Neurosci2024https://conductscience.org/library/papers/38372253PubMed
129057858From peptide to non-peptide. 3. Atropisomeric GPIIbIIIa antagonists containing the 3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione nucleus.J Med Chem1997https://conductscience.org/library/papers/9057858PubMed
1327634891CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway.Oncotarget2016https://conductscience.org/library/papers/27634891PubMed
1434572385Target-Oriented Synthesis of Marine Coelenterazine Derivatives with Anticancer Activity by Applying the Heavy-Atom Effect.Biomedicines2021https://conductscience.org/library/papers/34572385PubMed
1537393347
Transient receptor potential ankyrin 1 (TRPA1) mediates reactive oxygen species-induced Ca2+ entry, mitochondrial dysfunction, and caspase-3/7 activation in primary cultures of metastatic colorectal carcinoma cells.
Cell Death Discov2023https://conductscience.org/library/papers/37393347PubMed
1639274873Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign.Molecules2024https://conductscience.org/library/papers/39274873PubMed
1734039605BRD4 methylation by the methyltransferase SETD6 regulates selective transcription to control mRNA translation.Sci Adv2021https://conductscience.org/library/papers/34039605PubMed
1812848532Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis.J Am Chem Soc2003https://conductscience.org/library/papers/12848532PubMed
1937563469Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.Nat Metab2023https://conductscience.org/library/papers/37563469PubMed
2022067455SuperTarget goes quantitative: update on drug-target interactions.Nucleic Acids Res2012https://conductscience.org/library/papers/22067455PubMed

See all 106 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40705771

GET https://conductscience.org/api/papers/v1/40705771/authors?page=2